|
|
|
17 December, 2014
|
|
|
Emerging Markets
Indonesia “Most Promising” Emerging Market in 2015
With its new healthcare insurance scheme, Jaminan Kesehatan Nasional (JKN), aiming to cover all citizens by 2019, next year will see Indonesia emerge as the most promising emerging market for pharma investment, according the Frost & Sullivan’s Reenita Das. Das predicts more deals between global multinational pharma companies and local, home-grown companies in this region in 2015... Read more |
Europe
EU Review on Vaccination: A Shot in the Arm for Common Sense?
The conclusions on vaccination that European Union health ministers adopted this month contain several sound thoughts. Ministers said clearly: "An evidence-based, cost-effective, safe, and efficient immunization system is an integral part of a well-functioning health system." Given some of the recent public resistance to vaccinations in some parts of Europe, the statement is both necessary and helpful, writes Peter O’ Donnell... Read more
|
US
AmerisourceBergen: A Burgeoning Giant Steps Out
While globalization as a business strategy has been embraced by Big Pharma for the past decade, its network of providers, payers, distributors and service vendors has been slow to follow suit. A subtle and unmistakable shift is now underway among these low-profile drivers of the industry’s supply chain, however, and it is best summarized in the catch phrase: “follow the customer.” One strong example of the trend is the $100 billion sourcing and distribution behemoth AmerisourceBergen... Read more
|
Global
Toward 2015: A Pharm Exec Special
In this special digital issue of Pharm Exec: Transparency in Europe 2015; Cloud Technology: A 5-Year Outlook; Warehousing and the Future of the HCV Treatment Landscape; and more .... Read more
|
Global
Pharma in Argentina: An Interview with Juan Pablo Bagó
2014 marked the 80th anniversary of Laboratorios Bagó, a market leader in Argentina and also Latin America, with products in 47 countries. In this interview, Juan Pablo Bagó, general director of pharma in Argentina for the Bagó group, discusses the state of R&D in Argentina, and explains why his group is planning for a 75 percent of turnover from international markets in the coming years .... Read more
|
|
|
| //Sharp Packaging Services, part of UDG Healthcare (Dublin, Ireland), has appointed Mike O'Hara as Divisional Managing Director. In this role, Mr. O' Hara will have global responsibility for the Sharp Division, managing both the commercial packaging and the clinical business units.//Tony Zook, formerly Executive Vice President, Global Commercial Operations, at AstraZeneca has been appointed Chief Executive Officer of Innocoll AG (Athlone, Ireland) today announced that effectively immediately.//The Board of Directors of XTL Biopharmaceuticals (Herzliya, Israel) has appointed two new members, Dr. Jonathan Schapiro and Dr. Dobroslav Melamed.//Proteo Biotech AG (Kiel, Germany) has appointed Dr. Juergen Paal to its Management Board. As Chief Operating Officer, Dr. Paal will be responsible for Proteo's clinical development program, product launch preparation, business development and partnering initiatives.//Ziarco Group (Canterbury, UK) announced the addition of Mike Grey to its Board of Directors as an independent director.// |
|
|
|
|
|
